I.R.O. Nováková

2.2k total citations · 1 hit paper
52 papers, 1.6k citations indexed

About

I.R.O. Nováková is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, I.R.O. Nováková has authored 52 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 10 papers in Genetics and 9 papers in Oncology. Recurrent topics in I.R.O. Nováková's work include Blood Coagulation and Thrombosis Mechanisms (17 papers), Hemophilia Treatment and Research (14 papers) and Neutropenia and Cancer Infections (9 papers). I.R.O. Nováková is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (17 papers), Hemophilia Treatment and Research (14 papers) and Neutropenia and Cancer Infections (9 papers). I.R.O. Nováková collaborates with scholars based in Netherlands, France and United Kingdom. I.R.O. Nováková's co-authors include Bert Verbruggen, Eveline P. Mauser‐Bunschoten, Marijke van den Berg, H. Wessels, J.B.M. Boezeman, J. Peter Donnelly, B.E. de Pauw, Mirian C. H. Janssen, Hub Wollersheim and Ben de Pauw and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Blood.

In The Last Decade

I.R.O. Nováková

52 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Nijmegen Modification of the Bethesda Assay for Factor VIII:C Inhibitors: Improved Specificity and Reliability

1995 500 citations Bert Verbruggen, I.R.O. Nováková et al. profile →

Peers

Countries citing papers authored by I.R.O. Nováková

Since Specialization

Citations

This map shows the geographic impact of I.R.O. Nováková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I.R.O. Nováková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I.R.O. Nováková more than expected).

Fields of papers citing papers by I.R.O. Nováková

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I.R.O. Nováková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I.R.O. Nováková. The network helps show where I.R.O. Nováková may publish in the future.

Co-authorship network of co-authors of I.R.O. Nováková

This figure shows the co-authorship network connecting the top 25 collaborators of I.R.O. Nováková. A scholar is included among the top collaborators of I.R.O. Nováková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I.R.O. Nováková. I.R.O. Nováková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prolonged delay for controlling KPC-2–producing Klebsiella pneumoniae outbreak: The role of clinical management 2015 ·American Journal of Infection Control ·Tristan Delory, É. Seringe, (unknown), I.R.O. Nováková, Cyril Goulenok, (unknown), Sylvie Boyer, A. Carbonne, Thierry Naas, Pascal Astagneau	12
2	An ultrapure plasma-derived monoclonal antibody-purified factor IX concentrate (Nonafact®), results of phase III and IV clinical studies 2011 ·Haemophilia ·Eveline P. Mauser‐Bunschoten, Ilona Kleine Budde, S Łopaciuk, Mmw Koopman, F.J.M. van der Meer, I.R.O. Nováková, Paula F. Ypma, (unknown), Jerzy Windyga, Paul Strengers	9
3	Factor VIII genotype and inhibitor development in patients with haemophilia A: highest risk in patients with splice site mutations 2008 ·Haemophilia ·J. C. A. Boekhorst, (unknown), Roseline d’Oiron, J.‐M. Costa, I.R.O. Nováková, F. Ala, J. M. Lavergne, Waander L. van Heerde	28
4	The feasibility of total ankle prosthesis for severe arthropathy in haemophilia and prothrombin deficiency 2006 ·Haemophilia ·Huub J. L. van der Heide, I.R.O. Nováková, M.C. de Waal Malefijt	27
5	Thirteen novel mutations in the factor VIII gene in the Nijmegen haemophilia A patient population 2005 ·British Journal of Haematology ·J. C. A. Boekhorst, Bert Verbruggen, (unknown), Jean‐Marc Costa, (unknown), Paul Brons, Marian G.J. van Kraaij, I.R.O. Nováková, Waander L. van Heerde	13
6	Prophylactic effect of recombinant factor VIIa in factor VII deficient patients 2004 ·British Journal of Haematology ·(unknown), Rosalinde Masereeuw, (unknown), J. M. Lavergne, (unknown), Waander L. van Heerde, I.R.O. Nováková	33
7	Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy 2000 ·BJOG An International Journal of Obstetrics & Gynaecology ·E.F. van der Molen, Bert Verbruggen, I.R.O. Nováková, T.K.A.B. Eskes, L.A.H. Monnens, Henk J. Blom	76
8	Pseudotumor occurring in hemophilia 2000 ·Archives of Orthopaedic and Trauma Surgery ·(unknown), (unknown), (unknown), I.R.O. Nováková, C A van de Kaa	9
9	FACTOR VIIA DETERMINATION COMPARED TO D-DIMER IN DIAGNOSIS OF DEEP VENOUS THROMBOSIS 1997 ·Thrombosis Research ·Mirian C. H. Janssen, Bert Verbruggen, (unknown), I.R.O. Nováková	7
10	Acquired haemophilia A in women postpartum: management of bleeding episodes and natural history of the factor VIII inhibitor 1997 ·European Journal Of Haematology ·Jan Michiels, Karly Hamulyák, H K Nieuwenhuis, I.R.O. Nováková, Huub H.D.M. van Vliet	40
11	Diagnosis of deep vein thrombosis, an overview 1996 ·The Netherlands Journal of Medicine ·Mirian C. H. Janssen, Hub Wollersheim, I.R.O. Nováková, (unknown), (unknown), T Thien	8
12	A specific allele of the histidine‐rich glycoprotein (HRG) locus is linked with elevated plasma levels of HRG in a Dutch family with thrombosis 1995 ·British Journal of Haematology ·(unknown), (unknown), Bobby P. C. Koeleman, Dorret I. Boomsma, (unknown), (unknown), I.R.O. Nováková, E.J.P. Brommer, (unknown)	14
13	Neurological Complications in Children with Protein C Deficiency 1994 ·Neuropediatrics ·(unknown), Jan J. Rotteveel, Conny van Oostrom, I.R.O. Nováková	17
14	Efficacy of Itraconazole in the Prevention of Fungal Infections Among Neutropenic Patients with Hematologic Malignancies and Intensive Chemotherapy. A Double Blind, Placebo Controlled Study 1993 ·Leukemia & lymphoma ·Gerard Vreugdenhil, (unknown), J. Peter Donnelly, I.R.O. Nováková, John Raemaekers, (unknown), (unknown), B.E. de Pauw	84
15	The efficacy of itraconazole against systemic fungal infections in neutropenic patients: A randomised comparative study with amphotericin B 1991 ·Journal of Infection ·(unknown), I.R.O. Nováková, C.A.H.H.V.M. Verhagen, Willem E. Fibbe, B.E. de Pauw, J.W.M. van der Meer	71
16	Idiopathic thrombocythemia and pregnancy; a case report 1991 ·European Journal of Obstetrics & Gynecology and Reproductive Biology ·(unknown), I.R.O. Nováková, P.W.J. van Dongen	9
17	Ceftazidime with or without amikacin for the empiric treatment of localized infections in febrile, granulocytopenic patients 1991 ·Annals of Hematology ·I.R.O. Nováková, J. Peter Donnelly, B.E. de Pauw	13
18	Options and limitations of teicoplanin in febrile granulocytopenic patients 1990 ·British Journal of Haematology ·B.E. de Pauw, I.R.O. Nováková, J. Peter Donnelly	14
19	Amikacin plus Piperacillin versus Ceftazidime as Initial Therapy in Granulocytopenic Patients with Presumed Bacteremia 1990 ·Scandinavian Journal of Infectious Diseases ·I.R.O. Nováková, (unknown), Ben de Pauw	22
20	Factor XI Kinetics after Plasma Exchange in Severe Factor XI Deficiency 1986 ·Pathophysiology of Haemostasis and Thrombosis ·I.R.O. Nováková, C. A. M. van Ginneken, H Verbruggen, C. Haanen	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact